• Je něco špatně v tomto záznamu ?

Increased cardio-ankle vascular index in hyperlipidemic patients without diabetes or hypertension

P. Dobsak, V. Soska, O. Sochor, J. Jarkovsky, M. Novakova, M. Homolka, M. Soucek, P. Palanova, F. Lopez-Jimenez, K. Shirai,

. 2015 ; 22 (3) : 272-283. [pub] 20141022

Jazyk angličtina Země Japonsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16000572

Grantová podpora
NT13434 MZ0 CEP - Centrální evidence projektů

AIM: The cardio-ankle vascular index (CAVI) is a sensitive non-invasive marker of arterial stiffness and atherosclerosis. The aim of this work was to compare the CAVI values in patients with dyslipidemia (without diabetes mellitus and hypertension) and healthy controls. METHODS: A Total 248 subjects with dyslipidemia (104 men, 144 women), 55.0 (95% CI 30-70) years of age with combined hyperlipidemia or primary hypercholesterolemia and 537 healthy controls (244 men, 293 women) 40.0 (95% CI 26-62) years of age were included in this study. Fasting blood samples were collected to measure the serum total cholesterol, triglyceride, HDL-cholesterol and apolipoprotein A1 and B levels. The LDL cholesterol level was also calculated, and the CAVI was measured using the VaSera(®) 1500 system. RESULTS: The CAVI values were significantly higher in the dyslipidemic patients (8.08, 95% CI 6.00-10.05) than in the controls (7.11, 95% CI 5.77-9.05; p < 0.01). In addition, the CAVI values were elevated in both subgroups of patients with hypercholesterolemia (7.95, 95% CI 5.85-6.90; p < 0.01) and combined hyperlipidemia (8.30, 95% CI 6.60-10.15; p < 0.01) in comparison with those observed in the controls. After adopting the propensity score method in order to balance the confounding factors (age, gender, body mass index) and adjust the analysis for diastolic blood pressure, the CAVI values in the dyslipidemic patients remained significantly high (7.78, 95% CI 5.80-9.69) compared to that observed in the controls (7.31, 95% CI 5.44-9.35; p < 0.001). However, the CAVI values did not differ significantly between the controls and both subgroups of dyslipidemic patients(primary hypercholesterolemia, combined hyperlipidemia). CONCLUSIONS: The present findings demonstrated that dyslipidemia increases the CAVI values in comparison to that seen in healthy subjects.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16000572
003      
CZ-PrNML
005      
20190917112706.0
007      
ta
008      
160108s2015 ja f 000 0|eng||
009      
AR
024    7_
$a 10.5551/jat.24851 $2 doi
035    __
$a (PubMed)25342382
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ja
100    1_
$a Dobšák, Petr, $u Department of Sports Medicine and Rehabilitation, St. Anne's Faculty Hospital and Masaryk University of Brno, Czech Republic; International Clinical Research Center, Department of Cardiovascular Diseases, St. Anne's University Hospital Brno. Czech Republic. $d 1958- $7 xx0063744
245    10
$a Increased cardio-ankle vascular index in hyperlipidemic patients without diabetes or hypertension / $c P. Dobsak, V. Soska, O. Sochor, J. Jarkovsky, M. Novakova, M. Homolka, M. Soucek, P. Palanova, F. Lopez-Jimenez, K. Shirai,
520    9_
$a AIM: The cardio-ankle vascular index (CAVI) is a sensitive non-invasive marker of arterial stiffness and atherosclerosis. The aim of this work was to compare the CAVI values in patients with dyslipidemia (without diabetes mellitus and hypertension) and healthy controls. METHODS: A Total 248 subjects with dyslipidemia (104 men, 144 women), 55.0 (95% CI 30-70) years of age with combined hyperlipidemia or primary hypercholesterolemia and 537 healthy controls (244 men, 293 women) 40.0 (95% CI 26-62) years of age were included in this study. Fasting blood samples were collected to measure the serum total cholesterol, triglyceride, HDL-cholesterol and apolipoprotein A1 and B levels. The LDL cholesterol level was also calculated, and the CAVI was measured using the VaSera(®) 1500 system. RESULTS: The CAVI values were significantly higher in the dyslipidemic patients (8.08, 95% CI 6.00-10.05) than in the controls (7.11, 95% CI 5.77-9.05; p < 0.01). In addition, the CAVI values were elevated in both subgroups of patients with hypercholesterolemia (7.95, 95% CI 5.85-6.90; p < 0.01) and combined hyperlipidemia (8.30, 95% CI 6.60-10.15; p < 0.01) in comparison with those observed in the controls. After adopting the propensity score method in order to balance the confounding factors (age, gender, body mass index) and adjust the analysis for diastolic blood pressure, the CAVI values in the dyslipidemic patients remained significantly high (7.78, 95% CI 5.80-9.69) compared to that observed in the controls (7.31, 95% CI 5.44-9.35; p < 0.001). However, the CAVI values did not differ significantly between the controls and both subgroups of dyslipidemic patients(primary hypercholesterolemia, combined hyperlipidemia). CONCLUSIONS: The present findings demonstrated that dyslipidemia increases the CAVI values in comparison to that seen in healthy subjects.
650    _2
$a dospělí $7 D000328
650    _2
$a kotník $x krevní zásobení $7 D000842
650    _2
$a komplikace diabetu $x patofyziologie $7 D048909
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hyperlipidemie $x komplikace $x patofyziologie $7 D006949
650    _2
$a hypertenze $x komplikace $7 D006973
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Soška, Vladimír, $d 1953- $7 nlk20020120980
700    1_
$a Sochor, Ondřej $7 xx0131606
700    1_
$a Jarkovský, Jiří, $d 1976- $7 stk2008461294
700    1_
$a Novakova, Marie
700    1_
$a Homolka, Martin $7 xx0278728
700    1_
$a Souček, Miroslav, $d 1952- $7 xx0001907
700    1_
$a Palanová, Petra $7 xx0137220
700    1_
$a Lopez-Jimenez, Francisco
700    1_
$a Shirai, Kohji
773    0_
$w MED00008313 $t Journal of atherosclerosis and thrombosis $x 1880-3873 $g Roč. 22, č. 3 (2015), s. 272-283
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25342382 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160108 $b ABA008
991    __
$a 20190917113054 $b ABA008
999    __
$a ok $b bmc $g 1102853 $s 924778
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 22 $c 3 $d 272-283 $e 20141022 $i 1880-3873 $m Journal of atherosclerosis and thrombosis $n J Atheroscler Thromb $x MED00008313
GRA    __
$a NT13434 $p MZ0
LZP    __
$a Pubmed-20160108

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...